← Back to Search

18F-DCFPyL for Prostate Cancer

Phase 2
Waitlist Available
Led By Ashok Muthukrishnan, MD, MS
Research Sponsored by Ashok Muthukrishnan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

Study Summary

This trial will evaluate if 18F-DCFPyL PET imaging can help diagnose prostate cancer in men with increasing PSA levels.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Positive Predictive Value (PPV) (Per-patient)
Secondary outcome measures
Positive Predictive Value (PPV) (Per-region)

Side effects data

From 2019 Phase 3 trial • 208 Patients • NCT03739684
1%
Headache
1%
Fatigue
1%
Hypertension
100%
80%
60%
40%
20%
0%
Study treatment Arm
18F-DCFPyL Injection

Trial Design

1Treatment groups
Experimental Treatment
Group I: 18F-DCFPyL + PET imagingExperimental Treatment1 Intervention
Participants will receive a single dose of 18F-DCFPyL and undergo a PET imaging study. (The PET imaging may be repeated at a later date if the biopsy of the lesion is negative and if the lesion is present on follow-up imaging.)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
18F-DCFPyL
2019
Completed Phase 3
~350

Find a Location

Who is running the clinical trial?

Ashok MuthukrishnanLead Sponsor
Progenics Pharmaceuticals, Inc.Industry Sponsor
33 Previous Clinical Trials
4,903 Total Patients Enrolled
17 Trials studying Prostate Cancer
2,287 Patients Enrolled for Prostate Cancer
Ashok Muthukrishnan, MD, MSPrincipal Investigator - University of Pittsburgh - Associate Professor
University of Pittsburgh

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer
Ashok Muthukrishnan 2021. "18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04727736.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top